Preview

Rational Pharmacotherapy in Cardiology

Advanced search

COMPARATIVE PHARMACOEPIDEMIOLOGICAL ASSESSMENT OF ANTIHYPERTENSIVE DRUGS PRESCRIPTION IN OUTPATIENT PRACTICE IN KURSK AND CHISINAU

https://doi.org/10.20996/1819-6446-2018-14-3-402-407

Full Text:

Abstract

Aim. To study the structure of medical prescriptions of antihypertensive agents for patients with arterial hypertension (HT) in the outpatient practice of Kursk (Russia) and Chisinau (Republic of Moldova).

Material and methods. The questioning of doctors of medical organizations in Kursk and Chisinau was carried out as a one-stage descriptive study from October 2015 to February 2016. The questionnaires included questions on the pharmacoepidemiological aspects of prescribing antihypertensive drugs. Total number of respondents was 218, of them – 106 (26 cardiologists and 80 therapists) in Kursk and 112 (28 cardiologists and 84 therapists) in Chisinau.

Results. In the real practice for HT treatment doctors in Kursk used more often beta-adrenoblockers (BAB), somewhat less often – angiotensinconverting enzyme (ACE) inhibitors, then diuretics. The shares of calcium channels blockers (CCB) and angiotensin II receptors blockers (ARB) were small – 8.8 and 5.2%, respectively. In Chisinau doctors gave preference to ACE inhibitors, then diuretics and BAB. Frequency of CCB prescriptions was almost identical to that of ARA – 13.7 and 13.6%, respectively. The additional antihypertensives, including central action drugs and alpha-adrenoblockers, were used rarely in both Chisinau and Kursk (1.3 and 1.6%, respectively). Doctors of Chisinau, when carrying out combined pharmacotherapy, gave priority to free combinations of antihypertensive drugs (64.4%), fixed combinations were used in 26.7% of cases. In Kursk, the ratio of these specified tactics of combined therapy was 53.5 and 34.1%, respectively. Among the pharmaceutical companies whose medicines were preferred by doctors in Kursk and in Chisinau, the leading positions were taken by KRKA (38.0 and 25.4%, respectively), Gideon Richter (13.5 and 28.7%, respectively) and Berlin-Chemie (26.7 and 15.6%, respectively).

Conclusion. ACE inhibitors, diuretics, BAB were priority classes in the prescribing antihypertensive drugs according to survey of doctors in Kursk and Chisinau. In the conditions of the existing pharmaceutical market of Chisinau doctors used ARB and CCB more often than doctors from Kursk. The main share of doctor’s prescriptions in Kursk and Chisinau, considered both for group of antihypertensive drugs, and for certain representatives of each group of drugs, corresponds to the current recommendations on the pharmacotherapy of patients with HT. 

About the Authors

S. V. Povetkin
Kursk State Medical University
Russian Federation

MD, PhD, Professor, Head of Chair of Clinical Pharmacology,

Karla Marx ul., 3, Kursk, 305041 



O. V. Levashova
Kursk State Medical University
Russian Federation

MD, PhD, Associate Professor, Chair of Clinical Pharmacology,

Karla Marx ul., 3, Kursk, 305041 



V. I. Ghicavii
«Nicolae Testemitanu» State University of Medicine and Pharmacy
Moldova, Republic of

MD, PhD, Professor, Corresponding Member of Academy of Sciences of Moldova, Head of Chair of Pharmacology and Clinical Pharmacology,

165, Stefan cel Mare si Sfant, Bd., MD-2004, Chişinau



N. G. Batchinschi
«Nicolae Testemitanu» State University of Medicine and Pharmacy
Moldova, Republic of

MD, PhD, Professor, Chair of Pharmacology and Clinical Pharmacology, 

165, Stefan cel Mare si Sfant, Bd., MD-2004, Chişinau



L. A. Pjdgurschi
«Nicolae Testemitanu» State University of Medicine and Pharmacy
Moldova, Republic of

MD, PhD, Associate Professor, Chair of Pharmacology and Clinical Pharmacology,

165, Stefan cel Mare si Sfant, Bd., MD-2004, Chişinau



L. M. Turca
«Nicolae Testemitanu» State University of Medicine and Pharmacy
Moldova, Republic of

MD, PhD, Associate Professor, Chair of Pharmacology and Clinical Pharmacology,

165, Stefan cel Mare si Sfant, Bd., MD-2004, Chişinau



References

1. Leonova M.V., Steinberg L.L., Belousov Yu.B. et al. Results of a pharmacoepidemiological research of arterial hypertension PIFAGOR IV: adherence of doctors. Russian Journal of Cardiology. 2015;1:59- 66. (In Russ.) [Леонова М.В., Штейнберг Л.Л., Белоусов Ю.Б. и соавт. Результаты фармакоэпидемиологического исследования артериальной гипертонии ПИФАГОР IV: приверженность врачей. Российский Кардиологический Журнал. 2015;1:59-66]. doi: 10.15829/1560-4071- 2015-1-59-66.

2. Martsevich S.Y., Lukina Y.V., Zagrebelnyy A.V., et al.; on Behalf of the Working Groups of the Registries PROFILE and REСVASA. Combined antihypertensive therapy in real clinical practice. Focus on fixed combinations of antihypertensive drugs (According to the data of outpatient registries RECVASA and PROFILE). Rational Pharmacotherapy in Cardiology. 2017;13(3):323-9. (In Russ.) [Марцевич С.Ю., Лукина Ю.В., Загребельный А.В., и др. от имени рабочих групп регистров ПРОФИЛЬ и РЕКВАЗА. Комбинированная антигипертензивная терапия в реальной клинической практике. Фокус на фиксированные комбинации антигипертензивных препаратов (по данным амбулаторных регистров РЕКВАЗА и ПРОФИЛЬ). Рациональная Фармакотерапия в Кардиологии. 2017;13(3):323-9]. doi: 10.20996/1819-6446-2017-13-3-323-329.

3. Gatsura S.V., Gatsura O.A., Golosova A.N. Choice of the initial treatment for mild to moderate arterial hypertension in Moscow primary practice. Rational Pharmacotherapy in Cardiology. 2014;10(5):505- 8. (In Russ.) [Гацура С.В., Гацура О.А., Голосова А.Н. Выбор стартовой терапии для лечения артериальной гипертонии 1-2 степени в московской общетерапевтической практике. Рациональная Фармакотерапия в Кардиологии. 2014;10(5):505-8]. doi: 10.20996/1819- 6446-2014-10-5-505-508.

4. Diagnosis and treatment of arterial hypertension. The clinical guidelines. Sistemnie gipertenzii. 2010;3:5-26. (In Russ.) [Диагностика и лечение артериальной гипертензии. Клинические рекомендации. Системные Гипертензии. 2010;3:5-26].

5. Borovikov V.P., Borovikov I.P. STATISTICA. Statistical analysis and data processing in a Windows. Moscow: Filin; 1998. (In Russ.) [Боровиков В.П., Боровиков И.П. STATISTICA. Статистический анализ и обработка данных в среде Windows. М.: Филинъ; 1998].

6. Glantz S. Primer of biostatistics.7th Edition. New York: McGraw-Hill Education / Medical; 2011.

7. Rogova N.V., Korovina E.V., Pervy E.I., Leonova M.V. Assessment of rationality of arterial hypertension pharmacotherapy in medical institutions of Volgograd. Vestnik VolgGMU. 2013;4(48):16-8. (In Russ.) [Рогова Н.В., Коровина Е.В., Первий Е. И., Леонова М. В. Оценка рациональности фармакотерапии артериальной гипертензии в лечебных учреждениях г. Волгограда. Вестник ВолгГМУ. 2013;4(48):16‒8].

8. Kontsevaya A.V., Romanenko T.S., Vygodin V.A., Fitilev S.B. Pharmacoepidemiology and the efficacy of antihypertensive treatment in real-life practice of the cardiology referral clinic. Rational Pharmacotherapy in Cardiology. 2015;11(1):8-17. (In Russ.) [Концевая А.В., Романенко Т.С., Выгодин В.А., Фитилев С.Б. Фармакоэпидемиология и эффективность антигипертензивной терапии в реальной практике специализированного кардиологического учреждения. Рациональная Фармакотерапия в Кардиологии. 2015;11(1):8-17]. doi: 10.20996/1819-6446-2015-11-1-8-17.

9. Shvets G.I., Povetkin S.V. Pharmacoepidemiological aspects of doctor’s adherence of Oryol medical institutions to prescriptions of antihypertensive drugs. Rational Pharmacotherapy in Cardiology. 2008;4(1):6-9. (In Russ.) [Швец Г.И., Поветкин С.В. Фармакоэпидемиологические аспекты приверженности врачей лечебно-профилактических учреждений Орла назначению антигипертензивных препаратов. Рациональная Фармакотерапия в Кардиологии. 2008;4(1):6-9]. doi: 10.20996/1819-6446-2008-4-1-6-9.

10. Ponomareva A.I., Kompaniets O.G., Linchak R.M. et al. Pharmacoepidemiological study of diuretics in the treatment of arterial hypertension in the outpatient conditions. Sistemnyie Gipertenzii. 2014;1(3):48-52. (In Russ.) (Пономарева А.И., Компаниец О.Г., Линчак Р.М. и др. Фармакоэпидемиологическое исследование диуретиков при лечении гипетонической болезни в амбулаторных условиях. Системные Гипертензии. 2014;11(3):48-52].

11. Belovol A.N., Knyazkova P.N. Aldosterone receptor antagonists: clinical pharmacology and therapeutic efficiency in chronic heart failure. Mir Meditsinyi i Biologii. 2012;1(32):13-9. (In Russ.) [Беловол А.Н., Князькова П.Н. Антагонисты альдостероновых рецепторов: клиническая фармакология и терапевтическая эффективность при хронической сердечной недостаточности. Мир Медицины и Биологии. 2012;1(32):13-9].

12. Caraus A., Bitca A. Aldosterone antagonists - new perspectives in the treatment of arterial hypertension. Buletinul Academiei de Stiinte a Moldovei. 2010;2(25):35-41. (In Romans) [Cărăuş A., Bîtcă A. Antagonistii aldosteronului - perspective noi în tratamentul hipertensiunii arteriale severe. Buletinul Academiei de Ştiinţe a Moldovei. 2010;2(25):35-41].

13. Dzhumagulova A.S., Romanova T.A., Polupanov A.G. Pharmacoepidemiology of arterial hypertension in the Kyrgyz republic (according to the international research "INTEREPID"). Vestnik KRSU. 2016;14(4):67-70. (In Russ.) [Джумагулова А.С., Романова Т.А., Полупанов А.Г. Фармакоэпидемиология артериальной гипертензии в Кыргызской республике (по данным международного исследования “ИНТЕРЭПИД”). Вестник КРСУ. 2016;14(4):67-70].


For citation:


Povetkin S.V., Levashova O.V., Ghicavii V.I., Batchinschi N.G., Pjdgurschi L.A., Turca L.M. COMPARATIVE PHARMACOEPIDEMIOLOGICAL ASSESSMENT OF ANTIHYPERTENSIVE DRUGS PRESCRIPTION IN OUTPATIENT PRACTICE IN KURSK AND CHISINAU. Rational Pharmacotherapy in Cardiology. 2018;14(3):402-407. (In Russ.) https://doi.org/10.20996/1819-6446-2018-14-3-402-407

Views: 126


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)